Anzeige

Anti hypertensives

17. Feb 2017
Anzeige

Más contenido relacionado

Anzeige

Anti hypertensives

  1. ANTI-HYPERTENSIVES Dr. AMANULLA ABUL HASSAN CHENNAI
  2. BLOOD PRESSURE • Measure of pressure exerted on the lateral wall of the blood vessels by a flowing column of blood • Has two components – Systolic – Diastolic • Normal- 120/80 mm of Hg
  3. FACTORS INFLUENCING BP • Blood pressure = Cardiac output (CO)* Total peripheral resistance(TPR) • Cardiac output = Heart rate * Stroke volume • Stroke volume in turn depends upon the venous return and blood volume • TPR depends upon the size of the blood vessels mainly under the control of ANS • RAAS System
  4. JNC – 8 Classification Category Systolic Diastolic Normal <120 <80 Prehypertensive 120-139 80-89 Stage 1 Hypertensive 140-159 90-99 Stage 2 Hypertensive >160 >100 Isolated Systolic Hypertension >/=140 <80
  5. How Anti Hypertensives work? • By reducing blood volume and sodium concentration • By abolition of the sympathetic activity • By dilating the blood vessels • By inhibiting the RAAS system
  6. ANTIHYPERTENSIVES DIURETICS SYMPATHOPLEGICS VASODILATORS RAAS INHIBITOR
  7. DIURETICS • THIAZIDE-1st line drug in Management. – Hydrochlorthiazide- 12.5 to 50 mg – Chlorthaidone- 12.5 to 25mg – Indapamide- 1.25 to 5 mg . Longer acting • LOOP DIURETICS – Furosemide: 20 to 80 mg twice daily – Torsemide: 10 to 40 mg • POTASSIUM SPARING – Amiloride: 5 to 10 mg – Spiranolactone: 25 to 50 mg – Triamterene : 100 mg
  8. • Initial and prolonged effect? – Initailly: Both CO and TPR reduces – Later: CO comes to normal and TPR remains low • ADR: – Hypokalemia* – Hyperglycemia* (What to do in diabetics?) – Hyperuricemia *(What to do in GOUT?)
  9. ANTIHYPERTENSIVES DIURETICS SYMPATHOPLEGICS VASODILATORS RAAS INHIBITOR
  10. SYMPATHOPLEGICS DRUGS DECREASING CENTRAL SYMPATHETIC OUTFLOW GANGLION BLOCKER NEURON BLOCKERS ALPHA BLOCKERS BETA BLOCKERS
  11. CENTRAL SYMPATHETIC OUTFLOW INHIBITORS • CLONIDINE (0.1 to 0.2 mg twice daily) and ALPHA METHYL DOPA (250 to 500 mg twice daily) • Alpha 2 receptor agonists in brain • ADR: – Clonidine- Rebound Hypertension – Alpha Methyl Dopa- Hemolytic anemia • Moxonidine and Rilmenidine- Imidazoline receptors that modulate the activity of alpha 2 recpetors in brain • Better to add diuretics in prolonged use due to their sodium and water retention activity on prolonged use.
  12. SYMPATHOPLEGICS DRUGS DECREASING CENTRAL SYMPATHETIC OUTFLOW GANGLION BLOCKER NEURON BLOCKERS ALPHA BLOCKERS BETA BLOCKERS
  13. Ganglion Blockers • Nn type receptor blockers in Ganglion • Both sympathetic and parasympathetic system is blocked • Hence the side effects like Urinary retention and dry mouth • Hexamethonium and Trimethopan • Not used nowadays except in Aortic dissection
  14. SYMPATHOPLEGICS DRUGS DECREASING CENTRAL SYMPATHETIC OUTFLOW GANGLION BLOCKER NEURON BLOCKERS ALPHA BLOCKERS BETA BLOCKERS
  15. ADRENERGIC NEURON BLOCKERS • Reserpine, Guanethidine and Bretylium • Reserpine – Inhibits vesicular uptake of Adrenaline, Serotonin and Dopamine. – Serotonin- Depression and Suicidal tendencies • Guanethidine and Bretylium – Enters vesicles and displaces the Noradrenaline which in turn is metabolised – Active orally – Orthostatic hypotension – Not a first dose phenomenon.
  16. SYMPATHOPLEGICS DRUGS DECREASING CENTRAL SYMPATHETIC OUTFLOW GANGLION BLOCKER NEURON BLOCKERS ALPHA BLOCKERS BETA BLOCKERS
  17. Alpha Blockers • NON SELECTIVE: – Phenoxybenzamine: Pheochromocytoma – Phentolamine: Clonidine withdrawal – Tolazoline: Clonidine Withdrawal – Greater Tachycardia than selective • SELECTIVE: – DOC in Hypertension with BPH – First dose hypotension – Do not impair metabolism: Can be used in Diabetics, CAD and Gout – Prazosin : 0.5 to 20 mg – Terazosin: 1 to 5 mg – Doxazosin: 1 to 4 mg – Usually bed time doses
  18. SYMPATHOPLEGICS DRUGS DECREASING CENTRAL SYMPATHETIC OUTFLOW GANGLION BLOCKER NEURON BLOCKERS ALPHA BLOCKERS BETA BLOCKERS
  19. BETA BLOCKERS • Inhibition of Beta-1 receptors – Heart – JG apparatus – Brain • Usually Cardioselective drugs are used • Celiprolol, Oxeprenalol, Pindolol, Alprenolol and acebutalol • Esmolol, Atenolol, Nevibolol, Betaxolol and bisoprolol.
  20. • Metoprolol succinate 50-100mg and tartrate 50- 100mg twice daily • Nebivolol 5-10mg • Propranolol 40-120mg twice daily • Carvedilol 6.25-25mg twice daily • Bisoprolol 5-10mg • Labetalol 100-300mg twice daily • Carvedilol and Labetalol is both alpha and beta blockers
  21. • Not first line agents – reserve for post-MI/CHF • Cause fatigue and decreased heart rate • Adversely affect glucose metabolism • Mask hypoglycemic awareness • Non selective Beta blocker is contra-indiated in Asthmatics
  22. ANTIHYPERTENSIVES DIURETICS SYMPATHOPLEGICS VASODILATORS RAAS INHIBITOR
  23. Vasodilators • May be – Arteriolar: Potassium Channel openers, CCB, Dopamine agonist – Venodilator: Nitrates – Both arteriolar and Venous: Sodium nitroprussides, ARB, ACE-i, Alpha blockers.
  24. Vasodilators Calcium Channel Blockers Potassium Channel Openers NO Releasers Dopamine Agonist
  25. Calcium Channel Blockers Calcium Channel Blockers Phenylalkylamines Verapamil 80 to 120 mg thrice. ER- 240 to 480 mg stat Norverapamil Benzothiazipines Diltiazem180 to 360 mg Dihydropyridines Nifedipine, 30 to 90mg,Nicardipine, Amlodipine 5- 10mg etc
  26. • Blocks L- type calcium Channels • Reducing the frequency of opening of the calcium channels and that results in Smooth muscle relaxation and depression of heart. • Dihydropyridines are also called as peripheral CCBs- Reflex tachycardia more common – Nifedipine – Amlodipine- Maximum Half life – Nicardipine- Longest acting • Parentral • DOC of hypertensive emergency – Nimodipine: Cerebroselective – Clevidipine: Ultrashort acting recently approved for Emergencies • Verapamil> Diltiazem
  27. VERAPAMIL-WHERE AND WHERE NOT? WHERE? WHERE NOT? ANGINA SICK SINUS SYNDROME PSVT CHF HYPERTENSION ALONG WITH BETA BLOCKERS HOCM
  28. Vasodilators Calcium Channel Blockers Potassium Channel Openers NO Releasers Dopamine Agonist
  29. POTASSIUM CHANNEL OPENERS • Releases potassium from smooth muscle leading to hyperpolarisation and relaxation • Mainly Arteriolar • Hydralazine 25-100mg twice daily – Drug induced lupus erythamatosis – Metabolised by acetylation* – Also a nitrate releaser- Needs intact endothelium • Minoxidil 5-10mg – Prodrug activated to minoxidil sulphate by Phase 2 reaction – Safe in CKD – Hirsuitism
  30. Vasodilators Calcium Channel Blockers Potassium Channel Openers NO Releasers Dopamine Agonist
  31. NO releasers Releases NO Stimulate Guanalyl Cyclase Increases cGMP
  32. • Sodium nitroprusside – Short acting – Continous i.v infusion in hypertensive emergency – Accumulation of cyanide and produce toxicity – Lead to hypothyroidism due to accumulation of Thiocyanate.
  33. Vasodilators Calcium Channel Blockers Potassium Channel Openers NO Releasers Dopamine Agonist
  34. DOPAMINE AGONIST • FENOLDOPAM • D1 receptor agonist • Peripheral vasodilation • Suited for Patients with Renal diseases due to improved renal perfusion • ADR: – Hypokalemia – Increased intraocular pressure
  35. ANTIHYPERTENSIVES DIURETICS SYMPATHOPLEGICS VASODILATORS RAAS INHIBITOR
  36. RENIN INHIBITOR • Aliskiren • Remikiren • Enalkiren • Can be used orally for Chronic hypertension • Not in protocol provided by JNC
  37. ACE INHIBITORS • Captopril • Lisinopril • Benazapril • Enalapril- 5 to 20mg • Fosinopril and quinapril 10-40mg • Ramipril 5-10mg • Trandolapril 2-8mg
  38. Side effects • Dry cough • Angioedema • Taste Disturbance • Orthostatic Hypotension • Renal Failure* • Contraindicated: – Pregnancy – Hyperkalemia – Renal artery Stenosis
  39. Angiotensin Receptor Blockers. • Candesartan 8-32mg • Valsartan 80-320mg • Losartan 50-100mg – Competetive antagonist of TXA2 • Olmesartan 20-40mg • Telmisartan 20-80mg • Side effects are all same as ACE-i Other than Cough and Angioedema.
  40. Initial Drugs of Choice for Hypertension • ACE inhibitor (ACEI) • Angiotensin receptor blocker (ARB) • Thiazide diuretic • Calcium channel blocker (CCB)
  41. • CKD irrespective of age and Race – ACEi and ARB • Black people without CKD- Thiazide and CCB
  42. JNC 8 Strategies
  43. Goal BP
  44. Lifestyle changes • Smoking Cessation • Control blood glucose and lipids • Diet Eat healthy (i.e., DASH diet) Moderate alcohol consumption Reduce sodium intake to no more than 2,400 mg/day • Physical activity Moderate-to-vigorous activity 3-4 days a week averaging 40 min per session
Anzeige